Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TQ Therapeutics Acquires Juno Therapeutics | Contract Pharma

What are you searching for?

Sign in
Breaking News

TQ Therapeutics Acquires Juno Therapeutics

Acquisition supports TQ Therapeutics’ development of an ultra-short extracorporeal cell and gene therapy platform.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

TQ Therapeutics GmbH (TQx), a biotechnology company dedicated to advancing the field of cellular therapies through innovative technologies, has acquired Juno Therapeutics GmbH, a cell therapy company, through a share purchase agreement.

Juno GmbH is a German subsidiary of Juno Therapeutics, Inc., which is a wholly owned subsidiary of the global biopharmaceutical company, Bristol Myers Squibb. The financial terms of the agreement were not disclosed.

The acquisition of Juno GmbH will increase TQx’s cell therapy capabilities, expanding access to intellectual property and license agreements that will support the development of the company’s potentially transformative cell processing platform.

“This acquisition presents an incredible opportunity for us to continue development of our breakthrough ultra-short extracorporeal cell and gene therapy approach to create treatments of the future,” said Dr. Christian Eckert, CEO of TQx. “This strategic transaction reinforces our commitment to making cell and gene therapy broadly accessible to address the medical needs of many patients.”

Other Pharma Industry Acquisitions

Check out Contract Pharma’s 2024 Pharmaceutical Industry Mergers & Acquisitions Roundup.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics